Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Starting soon Not applicable

THE EFFECT OF STANDARD PATİENT-BASED AND WEB-BASED SİMULATİON ON NURSİNG STUDENTS' KNOWLEDGE AND CLİNİCAL SKİLLS İN FALL RİSK ASSESSMENT

NCT07557082 · tracked via the Priya Life Science Turkey tracker
Sponsor
ESRA ERTUĞRUL
Phase
Not applicable
Started
2026-04-27
Last updated
2026-04-29

Condition(s) studied

Patient SafetyFallSimulation Edication

Investigational drug(s) / intervention(s)

Standardized patientweb-based simulation

Standardized patient: The group receiving training with standard patients in a simulation laboratory environment.

web-based simulation: Group receiving training through web-based simulation in a laboratory environment.

Study summary

Introduction: Falls are the most frequently reported and preventable type of safety incident. Patient falls are the most common adverse events in hospitals. This situation impacts clinical outcomes and increases the financial burden on healthcare systems. Simulation is an important component of nursing education because it enhances patient care and ensures patient safety.

Objective: To comparatively examine the effect of standard patient-based and web-based simulation methods, implemented in addition to the same theoretical education provided to nursing students, on students' knowledge levels regarding fall risk assessment and their fall risk assessment skills in clinical practice.

Materials and Methods: The study was conducted during the spring semester of the 2025-2026 academic year with first-year students in the Department of Nursing at Aydın Adnan Menderes University as part of the Fundamentals of Nursing course. All participating students will complete theoretical classes in the classroom and practical sessions in the laboratory. The study using standard patient and web-based simulation applications will be conducted in the simulation laboratory of the Faculty of Nursing at Aydın Adnan Menderes University. Research data will be collected using the "Individual Information Form," the "Fall Knowledge Test for Preventing Patient Falls" prepared in accordance with the literature, and the "Fall Risk Assessment Skills Rubric." Research data will be collected over a 4-month period (February 9 - June 9, 2026). A written permission letter will be obtained from the institution to conduct the study. Participants will be provided with detailed information about the study, and both verbal and written consent will be obtained. For numerically measured data, a normal distribution analysis will be performed; based on the results of this analysis, "Pearson Chi-square" and "t-tests" will be used for variables showing a normal distribution.

Findings: The research findings will be presented based on the analyses conducted.

Conclusion: The results will be presented based on the research findings, and recommendations will be made accordingly.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Be a first-year student in the School of Nursing * Be willing to participate in the study * Have no absences at any point during the study * Have completed both theoretical and clinical training * Be willing to remain in the study throughout all phases * Be a student who is not currently working or has not previously worked as a nurse Exclusion Criteria: * Be a graduate of a vocational high school for health sciences * Be a student admitted through the Foreign Student Exam (YÖS) * Be a student who does not wish to participate in the research * Be a student who was admitted to the nursing program through the Vertical Transfer Exam (DGS) after graduating from a program offering an associate's degree in a health-related field

Primary outcome measure(s)

  • Planned Mean Change in Total Knowledge Score on the Fall Prevention Knowledge Test (0-28) — From enrollment to the 8th week of the intervention.
    Planned Mean Change in Total Knowledge Score on the Fall Prevention Knowledge Test (0-28) Total knowledge score will be measured using the Fall Prevention Knowledge Test among nursing students. Change from baseline will be assessed.

Trial sites (1)

FacilityCityRegionStatus
Süleyman Demirel University Eğirdir School of Health Services Isparta Eğirdir
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07557082 on ClinicalTrials.gov ↗ ← All trials in Turkey